Last reviewed · How we verify

NCT05106114: ACTIV'MARCHE

Intensive Gait Training Rehabilitation Protocol After Surgery in Cerebral Palsy

Completed NA Last updated 24 August 2025
What this trial tests

NA trial testing Intensive gait training rehabilitation protocole in Cerebral Palsy in 23 participants. Completed in 30 May 2024.

Timeline
28 May 2021
Primary endpoint
31 December 2023
30 May 2024

Quick facts

Lead sponsorFondation Ellen Poidatz
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment23
Start date28 May 2021
Primary completion31 December 2023
Estimated completion30 May 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Fondation Ellen Poidatz

Who can join

Adults 10 to 20, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the context of cerebral palsy, rehabilitation post Single-Event Multi-Level Surgery (SEMLS) is a long process. One year after surgery and rehabilitation, the functional benefits are usually less improved than the gait pattern. This may be caused by a lack of intensity in the final rehabilitation steps. Thus we created an intensive gait training rehabilitation protocole. This protocole associates 4 weeks of intensive rehabilitation in a healthcare center followed by 2 weeks of intensive rehabilitation at home. The objective of this study is to evaluate the efficiency of this protocol to improve walking speed and endurance, gross motor function et muscular strength.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Fondation Ellen Poidatz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106114.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing